Cancer Pain Management Market, [by Pain Type (Acute Pain, Chronic Pain); by Drug Type (Opioid, Non-steroidal anti-inflammatory drug, Aspirin, Corticosteroids, Anti-depressants); by Treatment (Immunotherapy, Radiotherapy, Chemotherapy, Home therapy); by End Users (Hospitals, Cancer Care Clinics, Others)]; and Geography - Trend, Analysis and Forecast till 2025

Report Summary

The GlobalCancer Pain Management Market Sizeis gaining traction owning to the factors such as ongoing research and development for developing new drugs, and rising number of patients suffering from cancer.

国家癌症研究所估计约5,80,350名美国人死于癌症。癌症是美国死亡率的第二个主要原因。每4人死亡占1人。疼痛是癌症中最令人着受的症状之一。尽管疼痛药物的可用性更大，但它通常在癌症患者中进行治疗。由于种植肿瘤的肿瘤而观察到的疼痛，摧毁了附近的组织，压力，骨骼和器官。在某些情况下，肿瘤会导致疼痛，因为它们释放损害内部身体部位的化学物质。癌症疼痛是暂时改变的症状，涉及炎症，神经性，压缩和缺血机制。癌症疼痛被分类为慢性和急性疼痛，这是明显的发病，并且延长了效果。慢性疼痛的特征在于疼痛耀斑，也称为突破性疼痛。

此外，由于各种癌症治疗方法，如外科疼痛，幽灵疼痛，程序和测试以及化疗和辐射治疗，导致癌症疼痛引起。癌症疼痛可以由各种止痛药控制，如阿片类药物，抗炎药，抗抑郁药，抗分泌药物和类固醇。

随着新药物开发的推出，作为一种新的癌症疼痛的新药，将推动癌症疼痛管理市场的增长。

The cancer pain market is primarily driven by rising prevalence of cancer worldwide. According to WHO, cancer is the second leading cause of death in North America, and was responsible for 8.8 million deaths in 2015. Additionally, National Cancer Institute estimated 1,685,210 new cases in the U.S. suffering from cancer in 2016. Similarly, various ongoing technological advancements for reducing pain caused due to surgical process would also influence the growth of this market. Moreover, the easy availability of the drugs that are used as painkiller would also propel the cancer pain management market.

However, side effects associated with the use of drugs that are used as a preferred treatment for cancer pain, and lack of awareness for using new technology for the pain treatment can hinder the market growth.

Global Cancer Pain Management Market Taxonomy

The cancer pain market is segmented on the basis of pain, drugs, route, treatment, and geography.

在疼痛类型的基础上，全球癌症疼痛管理市场规模被分割为;

• 急性疼痛
• Chronic Pain

On the basis of drug type, global cancer pain management market share is segmented as;

• Opioid
• Non-steroidal anti-inflammatory drug
• Aspirin
• Corticosteroids
• 抗抑郁药

On the basis of application type, global cancer pain management market size is segmented as;

• Immunotherapy
• 化疗
• Radiotherapy
• 家Therapy

在最终使用类型的基础上，全球癌症疼痛管理市场份额被分割为;

• Hospitals
• Cancer Care Clinics
• 其他

Geographically, the global cancer pain management market size is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

北美的大量领先制造商在该地区提高癌症疼痛管理市场。

On the basis of geography, North America is expected to dominate the全球癌症疼痛市场份额over forecast period. The primary factors influencing growth of cancer pain management market in this region are continuous efforts for new product development by the manufacturers, high number of patients suffering for cancer, and enhanced healthcare expenditure by the individuals and the government. While, Europe holds the second largest share in cancer pain management market owing to improved medical infrastructure for treating cancer pain. Also, there is a rising trend of consolidation between manufacturers for tapping this growing market.

Asia Pacific cancer pain management market is projected to witness lucrative market growth in the forecast period owning to the, increasing awareness for the use of various therapies as the treatment of cancer pain.

Key players in the global cancer pain management market are:

• Pfizer Inc.
• Mallinckrodt药业
• Teva Pharmaceuticals
• Johnson & Johnson Inc.
• Endo Pharmaceuticals
• Eli Lilly＆Company
• 生物制片业科学
• Prostrakan Group
• Sanofi S.A.
• Meda Pharmaceuticals
• Grunenthal Group
• Daiichi Sankyo